IL-38 is a biomarker for acute respiratory distress syndrome in humans and down-regulates Th17 differentiation in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IL-38 is a biomarker for acute respiratory distress syndrome in humans and down-regulates Th17 differentiation in vivo

Published:2020-01 Issue: Volume:210 Page:108315
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Chai Yu-sen,Lin Shi-hui,Zhang Mu,Deng Liangyong,Chen Yanqing,Xie Ke,Wang Chuan-jiang,Xu Fang

Funder

National Natural Science Foundation

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference41 articles.

1. Acute respiratory distress syndrome;Confalonieri;Eur. Respir. Rev.,2017

2. The acute respiratory distress syndrome;Matthay;J. Clin. Invest.,2012

3. The acute respiratory distress syndrome;Ware;N. Engl. J. Med.,2000

4. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group;Matthay;Am. J. Respir. Crit. Care Med.,2003

5. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management;Matthay;Am. J. Respir. Cell Mol. Biol.,2005

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying biomarkers deciphering sepsis from trauma-induced sterile inflammation and trauma-induced sepsis;Frontiers in Immunology;2024-01-12

2. Whether full‐length IL‐38 acts as a promoter or inhibitor in activating rheumatoid arthritis fibroblast‐like synoviocytes depends on IL‐1β;International Journal of Rheumatic Diseases;2024-01

3. Interleukin-38 and insulin resistance;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-09-11

4. The emerging role of IL‐38 in diseases: A comprehensive review;Immunity, Inflammation and Disease;2023-08

5. Interleukin-38 in atherosclerosis;Clinica Chimica Acta;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3